- Home
- ZNTL vs JHI Comparison
ZNTL vs JHI Comparison
Compare ZNTL & JHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- JHI
- Stock Information
- Founded
- ZNTL 2014
- JHI 1971
- Country
- ZNTL United States
- JHI United States
- Employees
- ZNTL N/A
- JHI N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- JHI Trusts Except Educational Religious and Charitable
- Sector
- ZNTL Health Care
- JHI Finance
- Exchange
- ZNTL Nasdaq
- JHI Nasdaq
- Market Cap
- ZNTL 105.8M
- JHI 123.0M
- IPO Year
- ZNTL 2020
- JHI N/A
- Fundamental
- Price
- ZNTL $1.99
- JHI $14.08
- Analyst Decision
- ZNTL Buy
- JHI
- Analyst Count
- ZNTL 7
- JHI 0
- Target Price
- ZNTL $8.46
- JHI N/A
- AVG Volume (30 Days)
- ZNTL 784.9K
- JHI 29.5K
- Earning Date
- ZNTL 08-06-2025
- JHI 01-01-0001
- Dividend Yield
- ZNTL N/A
- JHI 6.80%
- EPS Growth
- ZNTL N/A
- JHI N/A
- EPS
- ZNTL N/A
- JHI 1.05
- Revenue
- ZNTL $26,865,000.00
- JHI N/A
- Revenue This Year
- ZNTL N/A
- JHI N/A
- Revenue Next Year
- ZNTL N/A
- JHI N/A
- P/E Ratio
- ZNTL N/A
- JHI $12.47
- Revenue Growth
- ZNTL N/A
- JHI N/A
- 52 Week Low
- ZNTL $1.01
- JHI $11.63
- 52 Week High
- ZNTL $5.44
- JHI $13.40
- Technical
- Relative Strength Index (RSI)
- ZNTL 78.59
- JHI 60.43
- Support Level
- ZNTL $1.55
- JHI $13.97
- Resistance Level
- ZNTL $1.70
- JHI $14.13
- Average True Range (ATR)
- ZNTL 0.12
- JHI 0.07
- MACD
- ZNTL 0.05
- JHI -0.02
- Stochastic Oscillator
- ZNTL 91.43
- JHI 64.71
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.